Tag: Healthcare Policy

maryland-governor-signs-law-expanding-states-prescription-drug-affordability-board-powers

Maryland Governor Signs Law Expanding State’s Prescription Drug Affordability Board Powers

In a pretty big deal, Maryland Gov. Wes Moore went ahead and signed this bill that lets a state board keep working on making prescription drugs cheaper for everyone in the state, not just...
trumps-approach-to-drug-pricing-plan-what-to-expect

Trump’s Approach to Drug Pricing Plan: What to Expect

President Trump is like totally gonna try to push this “most-favored nation” policy next week to like bring down drug prices in the U.S. It’s gonna shake things up for sure, especially for the...
reforming-fda-advisory-committee-policy-for-conflict-of-nterest-free-decisions

Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions

Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee policy. Pitts, who served as the senior official in charge...
trumps-fda-and-nh-picks-fda-office-crunch-pharmalittle-update

Trump’s FDA and NIH Picks, FDA Office Crunch: Pharmalittle Update

As the week comes to a close, many of us are looking forward to some well-deserved rest and relaxation. Personally, I'm excited to spend time with loved ones, walk my furry friends, and enjoy...
rfk-jrs-stem-cell-deregulation-roundtable-red-flags-raised

RFK Jr.’s Stem Cell Deregulation Roundtable: Red Flags Raised

Renowned cell biology and human anatomy professor at UC Davis School of Medicine, Paul Knoepfler, introduces a new column, Lab Dish, focusing on regenerative medicine. The recent roundtable on regenerative medicine hosted by Health...
suspend-us-patents-on-medicines-to-fight-us-tariffs

Suspend U.S. patents on medicines to fight U.S. tariffs

In the wake of the recent imposition of 25% tariffs on goods from Canada by the Trump administration, the Canadian government is responding with tariffs of its own. Amidst this escalating trade conflict, there...
reforming-fda-to-help-rare-disease-patients

Reforming FDA to Help Rare Disease Patients

President Donald Trump has the potential to revolutionize the landscape of rare disease treatments and save countless American lives through strategic policy changes, innovative science, and strong leadership within government agencies. This ambitious claim...
medicare-to-negotiate-prices-of-diabetes-and-weight-loss-drugs

Medicare to Negotiate Prices of Diabetes and Weight Loss Drugs

Medicare to Negotiate Prices of Diabetes and Weight Loss DrugsIn a groundbreaking move, Medicare officials have announced plans to negotiate the prices of two widely-used drugs for diabetes and weight loss. Ozempic and Wegovy,...
medicare-coverage-of-wegovy-should-nclude-but-not-negotiate-price

Medicare Coverage of Wegovy Should Include, But Not Negotiate Price

Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has stirred a heated debate among policymakers and healthcare experts. The...
bidens-medicare-advantage-regulation-boosts-payments-to-nsurers

Biden’s Medicare Advantage Regulation Boosts Payments to Insurers

Biden's Medicare Advantage Regulation Boosts Payments to InsurersIn a groundbreaking move that could reshape the landscape of the Medicare Advantage industry, President Biden's Centers for Medicare and Medicaid Services recently unveiled a...
navigating-the-gops-healthcare-agenda-balancing-health-and-nsurance

Navigating the GOP’s Healthcare Agenda: Balancing Health and Insurance

RFK Jr.'s Unconventional Stance on Health Insurance In a surprising turn of events, Robert F. Kennedy Jr., known for his Make American Healthy Again movement, has been chosen by President Trump to lead the Department...
sanofi-faces-federal-threats-over-payment-terms-change-for-drug-discount-program

Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount Program

Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount ProgramA recent warning from a U.S. government agency has put pharmaceutical giant Sanofi in hot water over its decision to alter payment terms...

BREAKING NEWS

Top News